✨ Free AI Report
Vivani Medical, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Vivani Medical, Inc.
Company Research

Vivani Medical, Inc.: Business Overview, Financials & Competitive Analysis

Vivani Medical, Inc. scores 5/10 on the AskCyborg Cyborg Score (Mixed). NanoPortal implant technology offers transformative potential in chronic disease management if clinical trials succeed, but execution risk and financing needs weigh heavily on near-term prospects. The anticipated top-line data from LIBERATE-1 in mid-2025 represents a key catalyst for platform validation, while significant risks remain concerning future financing needs and.

What is Vivani Medical, Inc.'s industry? Vivani Medical, Inc. (vivani.com) operates in Biopharmaceutical/Medical Devices - Drug Delivery Systems. AskCyborg classifies Vivani Medical, Inc. under Biopharmaceutical/Medical Devices - Drug Delivery Systems in its company registry.

Vivani Medical is a clinical-stage biopharmaceutical company developing miniaturized and subdermal drug implants using its proprietary NanoPortal implant technology to address chronic diseases and medication non-adher...

5/ 10Mixed

Cyborg Score thesis

NanoPortal implant technology offers transformative potential in chronic disease management if clinical trials succeed, but...

Read the full analyst-debate transcript →
Industry Biopharmaceutical/Medical Devices - Drug Delivery Systems
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest Vivani Medical, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Vivani Medical, Inc.

AskCyborg analysts argue the bull and bear cases for Vivani Medical, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Vivani Medical, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Vivani Medical, Inc. Overview

Pro stress-test →

Vivani Medical is a clinical-stage biopharmaceutical company developing miniaturized and subdermal drug implants using its proprietary NanoPortal implant technology to address chronic diseases and medication non-adherence. The company is pursuing a pivotal opportunity in obesity/weight management by developing ultra long-acting implants that deliver therapy for six months or longer with a single administration.

Strategic Profile

Pro stress-test →

Formed in August 2022 through a merger of Second Sight Medical Products and Nano Precision Medical, Vivani inherited neurostimulation assets and NPM's NanoPortal drug implant technology, with a strategic pivot to prioritize the Biopharm pipeline. The company announced the spin-off of Cortigent, its wholly-owned subsidiary developing brain implant devices with cutting-edge neuromodulation technology.

Competitive Landscape

Pro stress-test →

Vivani's GLP-1 implant candidates aim to deliver the same active ingredients as market leaders like Ozempic, Trulicity, and Wegovy through an implant format. Competitors include established injectable GLP-1 providers (Novo Nordisk, Eli Lilly), long-acting GLP-1 formulations in development, and other implant-based delivery platforms targeting chronic disease adherence.

Industry Context

Vivani Medical, Inc. operates in Biopharmaceutical/Medical Devices - Drug Delivery Systems.

Key facts

Founded: 2022 · Headquarters: Alameda, CA, United States · Market cap: $78.2M

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Vivani Medical, Inc..

  • Lead drug implant candidates are designed to improve medication adherence and deliver smooth consistent therapeutic levels of GLP-1 for six months or longer with a single administration.
  • NPM-115 and NPM-119 are miniature, six-month GLP-1 implants under development for obesity/chronic weight management and type 2 diabetes treatment, respectively.
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • September 2025Announced record date for Cortigent neuromodulation subsidiary spin-off with expected NASDAQ listing
  • May 2025Completed $3.0 million equity financing to support R&D and clinical activities
  • +1 moreTrack every material event for Vivani Medical, Inc. as it happens. Explore monitoring →
Get alerted when Vivani Medical, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Ozempic/WegovyWeekly injectable GLP-1 agonist for diabetes and weight management→TrulicityWeekly injectable GLP-1 agonist for diabetes→Various long-acting GLP-1 formulationsMonthly or quarterly injectable alternatives→

Compare Vivani Medical, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Vivani Medical, Inc. operates in Biopharmaceutical/Medical Devices - Drug Delivery Systems. See how the rest of the sector scores on the Cyborg framework.

Top companies in Biopharmaceutical by Cyborg Score

Browse Biopharmaceutical/Medical Devices - Drug Delivery Systems research →
NEW · MCP server

Ask your AI assistant about Vivani Medical, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Vivani Medical, Inc. and its top competitor on Cyborg Score”
“What did Vivani Medical, Inc. do this quarter?”
“Is Vivani Medical, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does Vivani Medical, Inc. do?+
Vivani Medical is a clinical-stage biopharmaceutical company developing miniaturized and subdermal drug implants using its proprietary NanoPortal implant technology to address chronic diseases and medication non-adher...
What is Vivani Medical, Inc.'s Cyborg Score?+
Vivani Medical, Inc. has a Cyborg Score of 5/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Vivani Medical, Inc.'s main competitors?+
Named competitors include Ozempic/Wegovy, Trulicity, Various long-acting GLP-1 formulations. The full competitive landscape is in the AskCyborg report.
How can I get the full Vivani Medical, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Vivani Medical, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Vivani Medical, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Biopharmaceutical research

Companies in the same sector and named competitors, ranked by Cyborg Score.

9Eli Lilly and Company8argenx SE8Ascendis Pharma A/S8Avidity Biosciences, Inc.8BeOne Medicines AG8Celltrion, Inc.8Corcept Therapeutics Incorporated8Insmed Incorporated8Roivant Sciences Ltd.8Terns Pharmaceuticals, Inc.Top companies in Biopharmaceutical by Cyborg Score